论文信息 - Abstract GS5-02: Detection of circulating tumor DNA (ctDNA) after neoadjuvant chemotherapy is significantly associated with disease recurrence in early-stage triple-negative breast cancer (TNBC): Preplanned correlative results from clinical trial BRE12-158 - 字舞流文

Abstract GS5-02: Detection of circulating tumor DNA (ctDNA) after neoadjuvant chemotherapy is significantly associated with disease recurrence in early-stage triple-negative breast cancer (TNBC): Preplanned correlative results from clinical trial BRE12-158

J. Gregg | C. Isaacs | S. Badve | R. Nanda | Guanglong Jiang | C. Falkson | B. Schneider | A. Storniolo | T. Ballinger | M. Radovich | K. Miller | M. Thompson | L. Albacker | B. Hancock | F. Shen | R. Mahtani | F. Lynce | C. Chitambar | E. Cantor | E. Paplomata | C. Gallagher | D. Pavlick | K. Daily | Maureen E Cooper | M. Blaya | R. Walling | R. Graham | Casey L. Bales